Therefore, in the context of interstitial pneumonitis, an interesting question remains whether high pre-treatment levels of IP10 (and/or ET-1) levels could predispose patients to an altered risk of IFN-induced interstitial pneumonitis under IFNα therapy. Here, IFNA1 is linked to Interstitial pneumonitis.